ACHROMATOPSIA

Clinical trials for ACHROMATOPSIA explained in plain language.

Never miss a new study

Get alerted when new ACHROMATOPSIA trials appear

Sign up with your email to follow new studies for ACHROMATOPSIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Could a liver drug help people see color? tiny trial launched

Symptom relief Terminated

This early-phase trial tests whether an FDA-approved drug called glycerol phenylbutyrate (PBA) can improve vision in people with a rare form of color blindness caused by mutations in the ATF6 gene. Only 2 participants are enrolled, and they will take PBA three times daily while t…

Matched conditions: ACHROMATOPSIA

Phase: EARLY_PHASE1 • Sponsor: Columbia University • Aim: Symptom relief

Last updated Jun 26, 2026 15:34 UTC

ACHROMATOPSIA

Get alerted when new ACHROMATOPSIA trials appear

Could a liver drug help people see color? tiny trial launched